PlainRecalls
FDA Drug Critical Class I Terminated

Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044

Reported: May 15, 2019 Initiated: April 30, 2019 #D-1293-2019

Product Description

Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044

Reason for Recall

Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product

Details

Recalling Firm
Par Pharmaceutical, Inc.
Units Affected
4506 packs
Distribution
nationwide
Location
Chestnut Ridge, NY

Frequently Asked Questions

What product was recalled?
Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977 NDC 342023-172-044. Recalled by Par Pharmaceutical, Inc.. Units affected: 4506 packs.
Why was this product recalled?
Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product
Which agency issued this recall?
This recall was issued by the FDA Drug on May 15, 2019. Severity: Critical. Recall number: D-1293-2019.